Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Result of AGM

FOR IMMEDIATE RELEASE 18 June 2024 Bisichi Plc Company number 00112155  (“the Company”) (“Bisichi”) Outcome of AGM Bisichi announces, following the Company's 112[th] Annual General Meeting held today at 12 Charles II Street, St James, London SW1Y 4QU on Tuesday 18 June 2024 at 11:00 am, the outcome of the resolutions put to shareholders. On all Ordinary Resolutions 1-9 voting was conducted by way of a poll. Resolutions 1-9 were passed as Ordinary Resolutions. Full results of the poll for each resolution are shown below. Resolution VOTES %

Buy-back of shares in MTG during week 24, 2024

During the period between 10 June and 14 June 2024 Modern Times Group MTG AB (publ) (LEI code 549300E8NDODRSX29339) (“MTG”) repurchased, in total, 87,819 own class B shares (ISIN code SE0018012494) under the share repurchase program initiated by the Board of Directors.The share buy-backs form a part of the share repurchase program of a maximum of 5,789,385 shares for a maximum amount of SEK 400 million, which MTG announced on 16 May 2024. The share repurchase program, which runs from 17 May 2024 up until and including 30 April 2025, is being carried out in accordance with the Market Abuse

Pihlajalinna Oyj: Acquisition of own shares on June 18, 2024

Pihlajalinna Oyj: Acquisition of own shares on June 18, 2024 Pihlajalinna Oyj’s stock exchange release on June 18, 2024, at 07:00 p.m. EET Date June 18, 2024Exchange transaction BuyShare trading code PIHLISAmount, shares 1,000Average price/share (EUR) 9.6679Total cost (EUR) 9,667.90 After the acquisitions Pihlajalinna Oyj holds a total of 137,055 treasury shares. ON BEHALF OF PIHLAJALINNA OYJ Danske Bank A/S, Finland Branch  Antti Väliaho                        Jonathan Nyberg Additional Information

#24-221 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 18.06.2024

United Bankers Plc NOTIFICATION   18.06.2024 at 18:30   UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 18.06.2024   Date 18.06.2024  Exchange transaction Buy  Share class UNITED  Amount 200  Average price/share 18.5000 EURHighest price/share 18.5000 EURLowest price/share 18.5000 EURTotal price 3,700.00   EUR        The shares held by United Bankers Plc on 18.06.2024   UNITED 9,404         On behalf of United

JUMPGATE AB Press Release from the Extra General Meeting in Jumpgate AB June 18, 2024

Jumpgate AB (the “Company”) held an Extra General Meeting on Tuesday June 18, 2024 in the Company premises in Visby. The Annual General Meeting resolved in accordance with all previously announced proposed resolutions. Below follows a summary of the main resolutions that were made. The Extra General Meeting resolved to do a conversion issue of maximum 143 657 997 shares. The share price is 0.06 SEK and shall be paid by conversion of claims. Through the conversion issue, the Company´s registered share capital is increased with maximum 3 951 538.70 SEK. All resolutions were unanimous.

JUMPGATE AB Press Release from the Annual General Meeting in Jumpgate AB June 18, 2024

Jumpgate AB (the “Company”) held its Annual General Meeting on Tuesday June 18, 2024 in the Company premises in Visby. The Annual General Meeting resolved in accordance with all previously announced proposed resolutions. Below follows a summary of the main resolutions that were made. The Company´s income statement and balance sheet was adopted and it was resolved to balance the Company´s loss according to the approved balance sheet. The board members and the CEO were discharged from liability in accordance with the recommendation from the auditors. Martin Ekdal, Marcus Jacobs,

RayStation Used for First-Ever Radiotherapy Treatment with Hitachi’s OXRAY system

RaySearch Laboratories AB (publ) is pleased to announce a milestone in radiotherapy technology where RaySearch’s RayStation®* was used for the world’s first clinical treatment using OXRAY, a new treatment machine from Hitachi. The event took place on June 17 at Narita Memorial Hospital in Toyohashi, Japan.OXRAY represents a pioneering radiotherapy system featuring a Gimbal-mounted beam delivery system. RayStation was used to drive its motion tracking functionality, dual-source CBCT image-guided radiotherapy for precise patient positioning, and dynamic swing arc capabilities. Developed in

Salmon Evolution ASA: Contemplated Private Placement and Increased Debt Financing

18 June 2024: Salmon Evolution ASA (”Salmon Evolution” or the “Company”) announces that it has engaged Arctic Securities AS, DNB Markets, a part of DNB Bank ASA, and Nordea Bank Abp, filial i Norge as Joint Global Coordinators and Joint Bookrunners (together the “Managers”) to advise on and effect a contemplated private placement (the “Private Placement”) of new ordinary shares in the Company (the “Offer Shares”) raising gross proceeds of approximately NOK 350 million. The price per Offer Share in the Private Placement (“Offer Price”) will be set by the Company’s board of directors (the “

ChromoGenics AB (publ) publishes the Annual Report for 2023

ChromoGenics AB  (publ) today announces that it has published the Annual Report for 2023.The Annual Report, which is attached to the press release, is also available on the company website, https://chromogenics.com/annual-reports/The Annual Report can also be ordered from the company and distributed by post to the shareholders who request it.  Contact: Fredrik Fränding, CEOAnne-Marie Gullman, CFO & Head of Investor RelationsTel: +46 (0) 18 430 0430 E-mail: info@chromogenics.com ChromoGenics This statement has been made in a Swedish and

#24-220 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Cor Group Oy)

Nightingale Health Plc Company release 18 June 2024 at 5:25 p.m. (EEST)   Nightingale Health Plc (“Nightingale Health”) has received a notification on 18 June 2024 according to Chapter 9, Section 5 of the Finnish Securities Markets Act, stating that Cor Group Oy’s ownership of shares exceeds 10% of all shares and votes exceed 10% of all votes in Nightingale Health. Cor Group Oy's ownership and votes exceeded the notification threshold before 19 April 2024. The notification of exceeding the ownership and voting right threshold is retroactive because an amendment to the

Oblique Therapeutics and the KTH Royal Institute of Technology (KTH) have entered into a strategic collaboration to analyse protein structures using supercomputers.

Stockholm, Sweden - 10 June 2024 - Oblique Therapeutics, a leading biotechnology company specialising in the development of new drug candidates, is pleased to announce today that they have entered into an agreement with the KTH Royal Institute of Technology to utilise KTH’s state-of-the-art supercomputer resources for analysing protein structures. This partnership aims to accelerate research and development in the area of innovative treatments for various illnesses. The PDC Center for High Performance Computing (PDC) at KTH hosts the most powerful supercomputer within the National

Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Pasi Soininen)

Nightingale Health Plc Company release 18 June 2024 at 5:15 p.m. (EEST) Nightingale Health Plc (“Nightingale Health”) has received a notification on 18 June 2024 according to Chapter 9, Section 5 of the Finnish Securities Markets Act, stating that Pasi Soininen’s ownership of shares exceeds 5 % of all shares and votes exceed 20 % of all votes in Nightingale Health. Pasi Soininen’s ownership and votes exceeded the notification threshold before 19 April 2024. The notification of exceeding the ownership and voting right threshold is retroactive because an amendment to the

Situation update Aixia Group AB (publ)

Mölndal                                                                                     2024-06-18 Today marks an important milestone for Aixia, as we officially begin trading our share in the US on OTC Markets. (www.otcmarkets.com/stock/AIXAF/news) We are proud to announce a fantastic start to the year, with significant increases in both revenue and profit since the previous year and significant operational developments that have positioned us for continued success. Here follows an update on our current status and future prospects. Fantastic start to the yearWe have experienced

Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Teemu Suna)

Nightingale Health Plc Company release 18 June 2024 at 5:05 p.m. (EEST)   Nightingale Health Plc (“Nightingale Health”) has received a notification on 18 June 2024 according to Chapter 9, Section 5 of the Finnish Securities Markets Act, stating that Teemu Suna’s votes exceed 10 % of all votes in Nightingale Health. Teemu Suna’s votes exceeded the notification threshold before April 19, 2024. The notification of exceeding the voting right threshold is retroactive because an amendment to the Securities Markets Act entered into force on 19 April 2024, according to which the

Circio Holding ASA - Approval and publication of prospectus for the rights issue

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Oslo, 18 June 2024: Reference is made to the stock exchange announcements made by Circio Holding ASA (the "Company") on 29 May 2024, whereby the Company published the terms of the contemplated rights issue (the "Rights Issue") and related

Circio Holding ASA - Updated key information relating to the rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, THE UNITED KINGDOM, CANADA, AUSTRALIA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Oslo, 18 June 2024: Reference is made to the stock exchange announcement published by Circio Holding ASA (the "Company") on 29 May 2024 with key information relating to the rights issue in the Company (the "Rights Issue"). Please see

Circio Holding ASA - Updated information to the notice of annual general meeting 2024

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Oslo, 18 June 2024: Reference is made to the notice of the annual general meeting of Circio Holding ASA published on 29 May 2024 and the annual general meeting to be held on Wednesday 19 June 2024 at 10:00 hours (CEST) as a physical meeting at the

SSAB’s updated climate goals approved by the Science Based Targets initiative

SSAB’s near- and long-term carbon emissions reduction targets have been approved by the Science Based Targets initiative (SBTi). Approval means that the targets are scientifically based and in line with the SBTi’s raised requirements for companies to deliver on the goal of limiting global warming to 1.5°C. SSAB’s now validated long-term target is to reach net-zero greenhouse gas emissions for Scope 1, Scope 2 and Scope 3 by 2045*. The updated near-term target is a reduction of 48 percent in greenhouse gas emissions in Scope 1, Scope 2 and parts of Scope 3 by 2033 compared with

Perineal cut reduces the risk of serious birth injury

In first-time mothers requiring vacuum-assisted delivery, a lateral episiotomy (angled cut) in the tissue between the vaginal and anal opening more than halves the risk of obstetric anal sphincter injury, a severe form of perineal trauma between the vulva and anus. This according to a randomised clinical study led by researchers at Karolinska Institutet and Stockholm’s Danderyd Hospital, the results of which are published in The BMJ.Obstetric Anal Sphincter Injury (OASI), which involves the anal sphincter muscles, can lead to anal incontinence with difficulties retaining gas and faeces. It

Raisio plc: Managers´ transactions

Raisio plc Managers´ transactions 18 June 2024   MANAGERS’ TRANSACTIONS   Person subject to the notification requirement Name: Arto Tiitinen Position: Member of the Board/Deputy member Issuer: Raisio Oyj LEI: 74370083282NHIP4QD02   Notification type: INITIAL NOTIFICATION Reference number: 66610/5/4 ____________________________________________   Transaction date: 2024-06-18 Outside a trading venue Instrument type: SHARE ISIN: FI0009002943 Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE   Transaction details (1): Volume:

There are no items matching the current filter
There are no more items matching the current filter
Back to top